Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma-Reference-Cited by-同舟云学术

Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma

Published:2011-09 Issue:5 Volume:29 Page:502-507
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Baytekin Firat,Tuna Burcin,Mungan Ugur,Aslan Guven,Yorukoglu Kutsal

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference31 articles.

1. Prognostic markers in renal cell carcinoma;Ljungberg;Curr Opin Urol,2007

2. Expression of a novel anti-apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas;Lu;Cancer Res,1998

3. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas;Mahotka;Int J Cancer,2002

4. Survivin-ΔEx3 and survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties;Mahotka;Cancer Res,1999

5. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma;Krambeck;Clin Cancer Res,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxaliplatin activates P53/miR‐34a/survivin axis in inhibiting the progression of gastric cancer cells;Immunity, Inflammation and Disease;2024-09

2. P53 and survivin expression in renal cell carcinoma;Urology Annals;2023

3. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2021-02

4. Detection of urinary survivin using a magnetic particles‑based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B;Oncology Letters;2018-03-22

5. p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models;Urologic Oncology: Seminars and Original Investigations;2018-03